![Jelena Aleksic](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jelena Aleksic active positions
Companies | Position | Start | End |
---|---|---|---|
Pharmenable Ltd.
![]() Pharmenable Ltd. Pharmaceuticals: MajorHealth Technology Pharmenable Ltd. operates as a drug discovery company. It designs the next generation of small molecule drugs. The company was founded by Hannah Fiona Sore, Natalia Mateu, Jelena Aleksic, David Spring, and Andreas Bender in June 2016 and is headquartered in Histon, the United Kingdom. | Founder | 2016-05-31 | - |
Corporate Officer/Principal | 2016-05-31 | - |
Career history of Jelena Aleksic
Former positions of Jelena Aleksic
Companies | Position | Start | End |
---|---|---|---|
GeneAdviser Ltd.
![]() GeneAdviser Ltd. BiotechnologyHealth Technology GeneAdviser Ltd. operates an online ordering platform for genetic test services. It enables doctors and their local laboratories to find and order tests for rare diseases, cancer treatment and personalized medicine. The company was founded by Jelena Aleksic and Robert Stojnic and is headquartered in Cambridge, the United Kingdom. | Chief Executive Officer | - | - |
Founder | - | - |
Statistics
International
United Kingdom | 3 |
Operational
Founder | 2 |
Chief Executive Officer | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
GeneAdviser Ltd.
![]() GeneAdviser Ltd. BiotechnologyHealth Technology GeneAdviser Ltd. operates an online ordering platform for genetic test services. It enables doctors and their local laboratories to find and order tests for rare diseases, cancer treatment and personalized medicine. The company was founded by Jelena Aleksic and Robert Stojnic and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Pharmenable Ltd.
![]() Pharmenable Ltd. Pharmaceuticals: MajorHealth Technology Pharmenable Ltd. operates as a drug discovery company. It designs the next generation of small molecule drugs. The company was founded by Hannah Fiona Sore, Natalia Mateu, Jelena Aleksic, David Spring, and Andreas Bender in June 2016 and is headquartered in Histon, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Jelena Aleksic
- Experience